Vivimed Labs Ltd
NSE:VIVIMEDLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vivimed Labs Ltd
NSE:VIVIMEDLAB
|
IN |
|
Huajin International Holdings Ltd
HKEX:2738
|
CN |
|
Ambipar Participacoes e Empreendimentos SA
BOVESPA:AMBP3
|
BR |
|
Inspirato Inc
NASDAQ:ISPO
|
US |
|
Eagle High Plantations Tbk PT
IDX:BWPT
|
ID |
|
P
|
Powerwell Holdings Bhd
KLSE:PWRWELL
|
MY |
|
A
|
Activision Blizzard Inc
LSE:0H8X
|
US |
|
Hanover Foods Corp
OTC:HNFSB
|
US |
|
G
|
Gilead Sciences Inc
XHAM:GIS
|
US |
|
BASF India Ltd
NSE:BASF
|
IN |
|
Universal Entertainment Corp
TSE:6425
|
JP |
Bankruptcy Probability
Vivimed Labs Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vivimed Labs Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Vivimed Labs Ltd
NSE:VIVIMEDLAB
|
410.4m INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vivimed Labs Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vivimed Labs Ltd has total debt of 633.9m INR. This includes both short-term (0 INR) and long-term (633.9m INR) debt.
You can find a full breakdown on its Balance Sheet.
